CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

MAIAMAIA Biotechnology, Inc.

AMEX · PHARMACEUTICAL PREPARATIONS
Last close $1.18 · 2026-09-30
ABOUT
ExchangeAMEX
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$71.77M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-15 · Vitoc Vlad (Chief Executive Officer) · BUY
  • 2026-09-14 · Guerrero Ramiro (Director) · BUY
  • 2026-09-01 · Guerrero Ramiro (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders38
Shares held14,757,705
Value$21.47M
Percent of shares outstanding24.26%
As of quarter end2026-06-30
RECENT NEWS
  • MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
  • MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
  • MAIA Biotechnology advances Phase 3 lung cancer trial enrollment
  • MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
  • MAIA Biotechnology board member Guerrero buys $252,284 of company stock
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
MAIA Biotechnology, Inc. (MAIA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit